 <h1>Vabomere Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>meropenem / vaborbactam</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about meropenem / vaborbactam. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Vabomere.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to meropenem/vaborbactam: intravenous powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, meropenem / vaborbactam may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking meropenem / vaborbactam:</p><p>
<i>Less common</i>
</p><ul>
<li>Bluish color</li>
<li>changes in skin color</li>
<li>decreased urine</li>
<li>diarrhea</li>
<li>dry mouth</li>
<li>increased thirst</li>
<li>irregular heartbeat</li>
<li>loss of appetite</li>
<li>mood changes</li>
<li>muscle pain or cramps</li>
<li>nausea</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>seizures</li>
<li>swelling of the foot or leg</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Anxiety</li>
<li>black, tarry stools</li>
<li>bloody or cloudy urine</li>
<li>blurred vision</li>
<li>body aches or pain</li>
<li>chest discomfort</li>
<li>chest pain</li>
<li>chills</li>
<li>cold sweats</li>
<li>confusion</li>
<li>cool, pale skin</li>
<li>cough</li>
<li>depression</li>
<li>difficulty breathing</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>dryness or soreness of the throat</li>
<li>fast heartbeat</li>
<li>fever</li>
<li>flushed, dry skin</li>
<li>fruit-like breath odor</li>
<li>headache</li>
<li>hoarseness</li>
<li>increased hunger</li>
<li>increased urination</li>
<li>itching of the vagina or genitals</li>
<li>loss of consciousness</li>
<li>nervousness</li>
<li>nightmares</li>
<li>pain in the lower back or side</li>
<li>pain, redness, or swelling in the arm or leg</li>
<li>painful or difficult urination</li>
<li>runny nose</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>shakiness</li>
<li>slurred speech</li>
<li>sore mouth, throat, or tongue</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>stomach pain</li>
<li>sweating</li>
<li>tender, swollen glands in the neck</li>
<li>thick, white vaginal discharge with mild or no odor</li>
<li>trouble in swallowing</li>
<li>unexplained weight loss</li>
<li>unusual bleeding or bruising</li>
<li>voice changes</li>
<li>weakness or heaviness of the legs</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of meropenem / vaborbactam may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>decreased appetite</li>
</ul><p>
<!-- end intravenous powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to meropenem / vaborbactam: intravenous powder for injection</i></p><h3>General</h3><p>The most common side effects were headache, phlebitis/infusion site reactions, infusion site phlebitis, diarrhea, and nausea.  This drug was discontinued due to a side effect in 2.9% (8/272) of patients (compared to 5.1% [14/273] of patients using piperacillin-tazobactam); therapy was discontinued most commonly due to hypersensitivity and infusion-related reactions.  Death occurred in 0.7% of patients using this drug and in 0.7% of patients using piperacillin-tazobactam.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p>
<p><b>Uncommon</b> (0.1% to 1%): Dizziness, tremor, paresthesia, lethargy</p>
<p></p>
<p>Meropenem:</p>
<p>-Rare (0.01% to 0.1%): Convulsions<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Phlebitis/infusion site reactions (included infusion/injection site phlebitis, infusion site thrombosis, infusion site erythema), infusion site phlebitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Infusion site erythema, injection site phlebitis, infusion site thrombosis, infusion related reaction<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, nausea, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Abdominal distension, Clostridioides difficile colitis, oral candidiasis</p>
<p><b>Frequency not reported</b>: C difficile-associated diarrhea</p>
<p></p>
<p>Meropenem:</p>
<p>-Uncommon (0.1% to 1%): Abdominal pain<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity (included hypersensitivity, drug hypersensitivity, anaphylactic reaction, rash, urticaria, bronchospasm)</p>
<p><b>Uncommon</b> (0.1% to 1%): Anaphylactic reaction<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Increased ALT, increased AST</p>
<p></p>
<p>Meropenem:</p>
<p>-Uncommon (0.1% to 1%): Increased blood bilirubin</p>
<p>-Frequency not reported: Jaundice<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Pyrexia</p>
<p><b>Uncommon</b> (0.1% to 1%): Chest discomfort</p>
<p></p>
<p>Meropenem:</p>
<p>-Common (1% to 10%): Increased blood alkaline phosphatase, increased blood LDH</p>
<p>-Uncommon (0.1% to 1%): Pain<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hypokalemia, hypoglycemia</p>
<p><b>Uncommon</b> (0.1% to 1%): Decreased appetite, hyperkalemia, hyperglycemia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension</p>
<p><b>Uncommon</b> (0.1% to 1%): Vascular pain</p>
<p><b>Frequency not reported</b>: Deep vein thrombosis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Rash, urticaria</p>
<p></p>
<p>Meropenem:</p>
<p>-Uncommon (0.1% to 1%): Pruritus</p>
<p>-Postmarketing reports: Toxic epidermal necrolysis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, erythema multiforme, angioedema<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Leukopenia</p>
<p></p>
<p>Meropenem:</p>
<p>-Common (1% to 10%): Thrombocytosis/thrombocythemia</p>
<p>-Uncommon (0.1% to 1%): Neutropenia, eosinophilia, thrombocytopenia</p>
<p>-Frequency not reported: Decreased blood thromboplastin, decreased prothrombin time</p>
<p>-Postmarketing reports: Agranulocytosis, hemolytic anemia, positive direct and indirect Coombs test<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Increased blood creatine phosphokinase<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Hallucination, insomnia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Renal impairment</p>
<p><b>Frequency not reported</b>: Azotemia</p>
<p></p>
<p>Meropenem:</p>
<p>-Uncommon (0.1% to 1%): Increased blood creatinine, increased blood urea<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Bronchospasm</p>
<p><b>Frequency not reported</b>: Pharyngitis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Vulvovaginal candidiasis, incontinence<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Vabomere (meropenem-vaborbactam)." The Medicines Company, Parsippany, NJ. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What drugs are contained in Vabomere?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Vabomere (meropenem / vaborbactam)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: carbapenems/beta-lactamase inhibitors</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Vabomere &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Urinary Tract Infection</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to meropenem / vaborbactam: intravenous powder for injection</i></p><h3>General</h3><p>The most common side effects were headache, phlebitis/infusion site reactions, infusion site phlebitis, diarrhea, and nausea.  This drug was discontinued due to a side effect in 2.9% (8/272) of patients (compared to 5.1% [14/273] of patients using piperacillin-tazobactam); therapy was discontinued most commonly due to hypersensitivity and infusion-related reactions.  Death occurred in 0.7% of patients using this drug and in 0.7% of patients using piperacillin-tazobactam.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p><p><b>Uncommon</b> (0.1% to 1%): Dizziness, tremor, paresthesia, lethargy</p><p></p><p>Meropenem:</p><p>-Rare (0.01% to 0.1%): Convulsions<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Phlebitis/infusion site reactions (included infusion/injection site phlebitis, infusion site thrombosis, infusion site erythema), infusion site phlebitis</p><p><b>Uncommon</b> (0.1% to 1%): Infusion site erythema, injection site phlebitis, infusion site thrombosis, infusion related reaction<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, nausea, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Abdominal distension, Clostridioides difficile colitis, oral candidiasis</p><p><b>Frequency not reported</b>: C difficile-associated diarrhea</p><p></p><p>Meropenem:</p><p>-Uncommon (0.1% to 1%): Abdominal pain<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity (included hypersensitivity, drug hypersensitivity, anaphylactic reaction, rash, urticaria, bronchospasm)</p><p><b>Uncommon</b> (0.1% to 1%): Anaphylactic reaction<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Increased ALT, increased AST</p><p></p><p>Meropenem:</p><p>-Uncommon (0.1% to 1%): Increased blood bilirubin</p><p>-Frequency not reported: Jaundice<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Pyrexia</p><p><b>Uncommon</b> (0.1% to 1%): Chest discomfort</p><p></p><p>Meropenem:</p><p>-Common (1% to 10%): Increased blood alkaline phosphatase, increased blood LDH</p><p>-Uncommon (0.1% to 1%): Pain<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hypokalemia, hypoglycemia</p><p><b>Uncommon</b> (0.1% to 1%): Decreased appetite, hyperkalemia, hyperglycemia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension</p><p><b>Uncommon</b> (0.1% to 1%): Vascular pain</p><p><b>Frequency not reported</b>: Deep vein thrombosis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Rash, urticaria</p><p></p><p>Meropenem:</p><p>-Uncommon (0.1% to 1%): Pruritus</p><p>-Postmarketing reports: Toxic epidermal necrolysis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, erythema multiforme, angioedema<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Leukopenia</p><p></p><p>Meropenem:</p><p>-Common (1% to 10%): Thrombocytosis/thrombocythemia</p><p>-Uncommon (0.1% to 1%): Neutropenia, eosinophilia, thrombocytopenia</p><p>-Frequency not reported: Decreased blood thromboplastin, decreased prothrombin time</p><p>-Postmarketing reports: Agranulocytosis, hemolytic anemia, positive direct and indirect Coombs test<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Increased blood creatine phosphokinase<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Hallucination, insomnia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Renal impairment</p><p><b>Frequency not reported</b>: Azotemia</p><p></p><p>Meropenem:</p><p>-Uncommon (0.1% to 1%): Increased blood creatinine, increased blood urea<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Bronchospasm</p><p><b>Frequency not reported</b>: Pharyngitis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Vulvovaginal candidiasis, incontinence<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Vabomere (meropenem-vaborbactam)." The Medicines Company, Parsippany, NJ. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What drugs are contained in Vabomere?</li>
</ul><h2>More about Vabomere (meropenem / vaborbactam)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: carbapenems/beta-lactamase inhibitors</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Vabomere &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Urinary Tract Infection</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>